Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 31, 2019 - Issue 13-14
210
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Time-course transcriptomic alterations reflect the pathophysiology of polyhexamethylene guanidine phosphate-induced lung injury in rats

, &
Pages 457-467 | Received 22 Jul 2019, Accepted 03 Oct 2019, Published online: 23 Jan 2020

References

  • Araya J, Nishimura SL. 2010. Fibrogenic reactions in lung disease. Annu Rev Pathol Mech Dis. 5(1):77–98.
  • Armstrong RA. 2014. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 34(5):502–508.
  • Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien H, Wai C, et al. 2010. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med. 16(9):1009–1017.
  • Belperio JA, Dy M, Murray L, Burdick MD, Xue YY, Strieter RM, Keane MP. 2004. The role of the Th2 CC chemokine Lig and CCL17 in pulmonary fibrosis. J Immunol. 173(7):4692–4698.
  • Bhandary YP, Shetty SK, Marudamuthu AS, Gyetko MR, Idell S, Gharaee-Kermani M, Shetty RS, Starcher BC, Shetty S. 2012. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am J Physiol Lung Cell Mol Physiol. 302(5):L463–L473.
  • Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z, Galon J. 2009. ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 25(8):1091–1093.
  • Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A. 2009. Chemokines and chemokine receptors: an overview. Front Biosci. 14:540–551.
  • Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M. 2004. Connective tissue growth factor is crucial to inducing a profibrotic environment in “fibrosis-resistant” BALB/c mouse lungs. Am J Respir Cell Mol Biol. 31(5):510–516.
  • Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, Moore MW. 1994. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science. 265(5172):682–684.
  • Cheng T, Liu Q, Zhang R, Zhang Y, Chen J, Yu R, Ge G. 2014. Lysyl oxidase promotes bleomycin-induced lung fibrosis through modulating inflammation. J Mol Cell Biol. 6(6):506–515.
  • Cheresh P, Kim SJ, Tulasiram S, Kamp DW. 2013. Oxidative stress and pulmonary fibrosis. Biochim Biophys Acta. 1832(7):1028–1040.
  • Cho Y, Lim JH, Song MK, Jeong SC, Lee K, Heo Y, Kim TS, Ryu JC. 2017. Toxicogenomic analysis of the pulmonary toxic effects of hexanal in F344 rat. Environ Toxicol. 32(2):382–396.
  • Choi Y, Paek D. 2016. Humidifier disinfectants, unfinished stories. Environ Health Toxicol. 31:e2016004.
  • Cox TR, Bird D, Baker AM, Barker HE, Ho MW, Lang G, Erler JT. 2013. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res. 73(6):1721–1732.
  • Cui Y, Robertson J, Maharaj S, Waldhauser L, Niu J, Wang J, Farkas L, Kolb M, Gauldie J. 2011. Oxidative stress contributes to the induction and persistence of TGF-beta1 induced pulmonary fibrosis. Int J Biochem Cell Biol. 43(8):1122–1133.
  • Dong J, Yu X, Porter DW, Battelli LA, Kashon ML, Ma Q. 2016. Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents. Arch Toxicol. 90(2):385–402.
  • Driscoll KE. 2000. TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett. 112-113:177–183.
  • Du Bois RM. 2010. Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov. 9(2):129–140.
  • Fehrenbach H. 2001. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res. 2(1):33–46.
  • Garbacki N, Di Valentin E, Piette J, Cataldo D, Crahay C, Colige A. 2009. Matrix metalloproteinase 12 silencing: a therapeutic approach to treat pathological lung tissue remodeling?. Pulm Pharmacol Ther. 22(4):267–278.
  • Gerard C, Rollins BJ. 2001. Chemokines and disease. Nat Immunol. 2(2):108–115.
  • Gorowiec MR, Borthwick LA, Parker SM, Kirby JA, Saretzki GC, Fisher AJ. 2012. Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-beta1-dependent mechanism. Free Radic Biol Med. 52(6):1024–1032.
  • Haelens A, Wuyts A, Proost P, Struyf S, Opdenakker G, van Damme J. 1996. Leukocyte migration and activation by murine chemokines. Immunobiology. 195(4-5):499–521.
  • Jeon BH, Park YJ. 2012. Frequency of humidifier and humidifier disinfectant usage in Gyeonggi Province. Environ Health Toxicol. 27:e2012002.
  • Kang HR, Cho SJ, Lee CG, Homer RJ, Elias JA. 2007. Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J Biol Chem. 282(10):7723–7732.
  • Kayanoki Y, Fujii J, Suzuki K, Kawata S, Matsuzawa Y, Taniguchi N. 1994. Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. J Biol Chem. 269(22):15488–15492.
  • Kim HR, Lee K, Park CW, Song JA, Shin da Y, Park YJ, Chung KH. 2016. Polyhexamethylene guanidine phosphate aerosol particles induce pulmonary inflammatory and fibrotic responses. Arch Toxicol. 90(3):617–632.
  • Kim MS, Jeong SW, Choi SJ, Han JY, Kim SH, Yoon S, Oh JH, Lee K. 2017. Analysis of genomic responses in a rat lung model treated with a humidifier sterilizer containing polyhexamethyleneguanidine phosphate. Toxicol Lett. 268:36–43.
  • Korea Centers for Disease Control and Prevention (KCDC). 2011. Interim report of epidemiologic investigation of lung injury with unknown causes in Korea. KCDC Public Health Weekly Rep. 4:817–818.
  • Lee SJ, Park JH, Lee JY, Jeong YJ, Song JA, Lee K, Kim DJ. 2016. Establishment of a mouse model for pulmonary inflammation and fibrosis by intratracheal instillation of polyhexamethyleneguanidine phosphate. J Toxicol Pathol. 29(2):95–102.
  • Lipson KE, Wong C, Teng Y, Spong S. 2012. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogen Tissue Rep. 5:S24.
  • Liu RM, Gaston Pravia KA. 2010. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Rad Biol Med. 48(1):1–15.
  • Lopez-Novoa JM, Nieto MA. 2009. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 1:303–314.
  • Luster AD. 1998. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med. 338(7):436–445.
  • Madala SK, Pesce JT, Ramalingam TR, Wilson MS, Minnicozzi S, Cheever AW, Thompson RW, Mentink-Kane MM, Wynn TA. 2010. Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. JI. 184(7):3955–3963.
  • Madtes DK, Elston AL, Kaback LA, Clark JG. 2001. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 24(5):599–607.
  • Manoury B, Caulet-Maugendre S, Guénon I, Lagente V, Boichot E. 2006. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int J Immunopathol Pharmacol. 19(3):471–487.
  • Mashat BH. 2016. Polyhexamethylene biguanide hydrochloride: features and application. Br J Environ Sci. 4:49–55.
  • Matute-Bello G, Wurfel MM, Lee JS, Park DR, Frevert CW, Madtes DK, Shapiro SD, Martin TR. 2007. Essential role of MMP-12 in fas-induced lung fibrosis. Am J Respir Cell Mol Biol. 37(2):210–221.
  • Nagao T, Okura T, Irita J, Jotoku M, Enomoto D, Desilva VR, Miyoshi K, Kurata M, Matsui Y, Uede T, et al. 2012. Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy. Nephron Extra. 2(1):87–103.
  • Noble PW, Barkauskas CE, Jiang D. 2012. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest. 122(8):2756–2762.
  • O’Donoghue RJ, Knight DA, Richards CD, Prêle CM, Lau HL, Jarnicki AG, Jones J, Bozinovski S, Vlahos R, Thiem S, McKenzie BS, et al. 2012. Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med. 4:939–951.
  • Park S, Lee K, Lee EJ, Lee SY, In KH, Kim HK, Kang MS. 2014. Humidifier disinfectant-associated interstitial lung disease in an animal model induced by polyhexamethylene guanidine aerosol. Am J Respir Crit Care Med. 190(6):706–708.
  • Protasov A, Bardeau J-F, Morozovskaya I, Boretska M, Cherniavska T, Petrus L, Tarasyuk O, Metelytsia L, Kopernyk I, Kalashnikova L, et al. 2017. New promising antifouling agent based on polymeric biocide polyhexamethylene guanidine molybdate. Environ Toxicol Chem. 36(9):2543–2551.
  • Rammah M, Dandachi F, Salman R, Shihadeh A, El-Sabban M. 2012. In vitro cytotoxicity and mutagenicity of mainstream waterpipe smoke and its functional consequences on alveolar type II derived cells. Toxicol Lett. 211(3):220–231.
  • Ramos H, Shannon P, Aebersold R. 2008. The protein information and property explorer: an easy-to-use, rich-client web application for the management and functional analysis of proteomic data. Bioinformatics. 24(18):2110–2111.
  • Rao KM, Ma JY, Meighan T, Barger MW, Pack D, Vallyathan V. 2005. Time course of gene expression of inflammatory mediators in rat lung after diesel exhaust particle exposure. Environ Health Perspect. 113(5):612–617.
  • Riise GC, Ahlstedt S, Larsson S, Enander I, Jones I, Larsson P, Andersson B. 1995. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax. 50(4):360–365.
  • Saito F, Tasaka S, Inoue K, Miyamoto K, Nakano Y, Ogawa Y, Yamada W, Shiraishi Y, Hasegawa N, Fujishima S, et al. 2008. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol. 38(5):566–571.
  • Selman M, Ruiz V, Cabrera S, Segura L, Ramírez R, Barrios R, Pardo A. 2000. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?. Am J Physiol Lung Cell Mol Physiol. 279(3):L562–L574.
  • Shetty SK, Bhandary YP, Marudamuthu AS, Abernathy D, Velusamy T, Starcher B, Shetty S. 2012. Regulation of airway and alveolar epithelial cell apoptosis by p53 induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury. Am J Respir Cell Mol Biol. 47(4):474–483.
  • Song JA, Park HJ, Yang MJ, Jung KJ, Yang HS, Song CW, Lee K. 2014. Polyhexamethyleneguanidine phosphate induces severe lung inflammation, fibrosis, and thymic atrophy. Food Chem Toxicol. 69:267–275.
  • Song MK, Choi HS, Lee HS, Ryu JC. 2014. Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 27(8):1362–1370.
  • Song MK, Lee HS, Ryu JC. 2015. Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity. Toxicology. 334:111–121.
  • Villard J, Dayer P, Hamacher J, Aubert JD, Schlegel H, Nicod LP. 1995. GRO alpha and interleukin 8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med. 152(5):1549–1554.
  • Vitt A, Sofrata A, Slizen V, Sugars RV, Gustafsson A, Gudkova EI, Kazeko LA, Ramberg P, Buhlin K. 2015. Antimicrobial activity of polyhexamethylene guanidine phosphate in comparison to chlorhexidine using the quantitative suspension method. Ann Clin Microbiol Antimicrob. 14(1):36.
  • Wang KX, Denhardt DT. 2008. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19(5–6):333–345.
  • Williams MC. 2003. Alveolar type I cells: molecular phenotype and development. Annu Rev Physiol. 65(1):669–695.
  • Xiao X, Gang Y, Gu Y, Zhao L, Chu J, Zhou J, Cai X, Zhang H, Xu L, Nie Y, et al. 2012. Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation. Dig Dis Sci. 57(11):2883–2891.
  • Yadav A, Saini V, Arora S. 2010. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta. 411(21–22):1570–1579.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.